Scandion Oncology A/S Financial Flexibility Index
Scandion Oncology A/S financial flexibility index. Scandion Oncology A/S (SCOL) has a Financial Flexibility Index of -0.18x as of December 2024. Free cash flow of Skr-1.82 Million (operating CF Skr-1.82 Million minus capex Skr0.00) represents 0% of total liabilities (Skr10.01 Million). See how much free cash does Scandion Oncology A/S generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Scandion Oncology A/S (2017–2024)
Financial flexibility index of Scandion Oncology A/S from 2017 to 2024. Historical Financial Flexibility Index trend for Scandion Oncology A/S across 8 annual periods. Explore SCOL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Scandion Oncology A/S Financial Flexibility Index by Year (2017–2024)
Scandion Oncology A/S financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Scandion Oncology A/S. For the full cash flow conversion analysis, see SCOL cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.75x | Skr-27.52 Million | Skr-27.52 Million | Skr10.01 Million | ▲ +81.3% |
| 2023 | -14.74x | Skr-50.67 Million | Skr-50.67 Million | Skr3.44 Million | ▼ -307.2% |
| 2022 | -3.62x | Skr-69.03 Million | Skr-69.44 Million | Skr19.07 Million | ▲ +14.6% |
| 2021 | -4.24x | Skr-49.48 Million | Skr-49.80 Million | Skr11.68 Million | ▼ -643.5% |
| 2020 | -0.57x | Skr-17.41 Million | Skr-17.45 Million | Skr30.54 Million | ▲ +90.8% |
| 2019 | -6.21x | Skr-9.71 Million | Skr-9.96 Million | Skr1.56 Million | ▲ +53.4% |
| 2018 | -13.33x | Skr-13.23 Million | Skr-13.28 Million | Skr992.64K | ▼ -496.0% |
| 2017 | -2.24x | Skr-1.14 Million | Skr-1.19 Million | Skr509.02K | — |